Pasigna, Encarnacion V.
HRN: 02-41-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
CEFTRIAXONE 1G (VIAL)
06/08/2025
06/14/2025
IV
2g
OD
Complicated UTI, CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes